Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Quest Diagnostics    DGX

QUEST DIAGNOSTICS

(DGX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Strengths
  • The stock is in a well-established, long-term rising trend above the technical support level at 91.47 USD
Weaknesses
  • The stock is close to a major daily resistance at USD 116.02, which should be gotten rid of so as to gain new appreciation potential.
  • The group shows a rather high level of debt in proportion to its EBITDA.
  • With a 2020 P/E ratio at 31.2 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
  • Revenue estimates are regularly revised downwards for the current and coming years.
  • For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
Ratings chart
Sector Healthcare Facilities & Services - NEC
1st jan.Capitalisation (M$)Investor Rating
QUEST DIAGNOSTICS5.58%15 451
CVS HEALTH CORPORATION-11.20%86 229
HCA HEALTHCARE, INC.-23.10%38 374
FRESENIUS MEDICAL CARE AG &..10.92%23 512
LABORATORY CORPORATION OF A..3.36%16 996
PING AN HEALTHCARE AND TECH..78.01%13 934
DAVITA INC.3.99%9 587
UNIVERSAL HEALTH SERVICES-23.02%9 379
CHEMED CORPORATION8.21%7 545
ENCOMPASS HEALTH CORPORATIO..7.81%7 424
WINNING HEALTH TECHNOLOGY G..52.34%5 225
RYMAN HEALTHCARE LIMITED-20.39%3 989
JINXIN FERTILITY GROUP LIMI..0.96%3 297
KORIAN-22.52%2 950
BUMRUNGRAD HOSPITAL-21.43%2 875
HMS HOLDINGS CORP.3.75%2 715
More Results
Financials (USD)
Sales 2020 7 215 M
EBIT 2020 833 M
Net income 2020 507 M
Debt 2020 3 548 M
Yield 2020 1,93%
P/E ratio 2020 31,2x
P/E ratio 2021 18,3x
EV / Sales2020 2,63x
EV / Sales2021 2,36x
Capitalization 15 451 M
Upcoming event on QUEST DIAGNOSTICS
Surperformance© ratings
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes